MAP 8.82% 18.5¢ microba life sciences limited

Ann: Sonic Acquires 19.9% Microba Stake and Enters Partnership, page-3

  1. 9,820 Posts.
    lightbulb Created with Sketch. 971
    It is becoming clear that pathology companies are beginning to view microbiome testing as a regular segment of pathology testing.

    Microba have the worlds leading platform and biggest library of microbiomes by several multiples.

    Microba is laying the infrastructure to be the world's dominant microbiome tester,
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.